Identification of biomarkers associated with inflammatory response in Parkinson's disease by bioinformatics and machine learning.

Journal: PloS one
Published Date:

Abstract

Parkinson's disease (PD) is a common and debilitating neurodegenerative disorder. The inflammatory response is essential in the pathogenesis and progression of PD. The goal of this study is to combine bioinformatics and machine learning to screen for biomarker genes related to the inflammatory response in PD. First, differentially expressed genes associated with inflammatory response were screened, PPI networks were constructed and enriched for analysis. LASSO, SVM-RFE and Random Forest algorithms were used to screen biomarker genes. Then, ROC curves were drawn and PD risk predicting models were constructed on the basis of the biomarker genes. Finally, drug sensitivity analysis, mRNA-miRNA network construction and single-cell transcriptome data analysis were performed. The experimental results showed that we screened 31 differentially expressed genes related to inflammatory response. Signaling pathways such as cytokine activity were associated with these genes. Three biomarkers were identified using machine learning algorithms: IL18R1, NMUR1 and RELA. Seventeen co-associated miRNAs were identified by the mRNA-miRNA network as possible regulatory nodes in PD. Finally, these three biomarkers were found to be closely associated with T cells, Endothelial cells, excitatory neurons, inhibitory neurons, and other cells in single-cell transcriptomic analysis. In conclusion, IL18R1, NMUR1 and RELA could be potential therapeutic targets for PD in inflammatory response and new biomarkers for PD diagnosis.

Authors

  • Yatan Li
    Department of Pharmacy, the Second Affiliated Hospital of Xinjiang Medical University, Urumqi, China.
  • Wei Jia
    Key Laboratory of Systems Biomedicine (Ministry of Education), Shanghai Center for Systems Biomedicine, Shanghai Jiao Tong University, Shanghai, China.
  • Chen Chen
    The George Institute for Global Health, Faculty of Medicine, University of New South Wales, Sydney, NSW, Australia.
  • Cheng Chen
    Key Laboratory of Precision and Intelligent Chemistry, School of Chemistry and Materials Science, University of Science and Technology of China, China.
  • Jinchao Chen
    College of Information Science and Engineering, Xinjiang University, Urumqi, China.
  • Xinling Yang
    Xinjiang Key Laboratory of Neurology, Urumqi, China.
  • Pei Liu
    School of Life Sciences, Nanjing University, State Key Laboratory of Pharmaceutical Biotechnology, Nanjing 210000, China.